This article is more than 5 years old. Information may no longer be current.

Insurance coverage of Vyzulta expands with Express Scripts

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Express Scripts will begin covering Vyzulta under an agreement with Bausch + Lomb, according to a press release.

Vyzulta (latanoprostene bunod ophthalmic solution 0.024%), indicated for reducing IOP in patients with open-angle glaucoma or ocular hypertension, will be covered under an access position on the commercial Express Scripts National Preferred and Basic formularies, the release said.

“We are proud of this achievement as it signifies the health care community’s recognition of the benefit Vyzulta may offer glaucoma patients,” Tracy Valorie, Bausch + Lomb’s senior vice president and general manager of U.S. Pharmaceuticals and Surgical, said in the release.